Gregory Liebbe - Ventas President
| VTR Stock | USD 43.56 0.43 1.00% |
President
Mr. Gregory R. Liebbe is Senior Vice President Chief Accounting Officer Controller of the Company. Prior to this appointment Mr. Liebbe was Vice President Accounting for the Company. since 2015.
| Tenure | 9 years |
| Address | 353 North Clark Street, Chicago, IL, United States, 60654-4708 |
| Phone | 877 483 6827 |
| Web | https://www.ventasreit.com |
Ventas Management Efficiency
The company has Return on Asset of 0.0165 % which means that on every $100 spent on assets, it made $0.0165 of profit. This is way below average. Ventas' management efficiency ratios could be used to measure how well Ventas manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/25/2024, Return On Tangible Assets is likely to grow to -0.0018. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Ventas' Non Current Assets Total are relatively stable compared to the past year. As of 04/25/2024, Other Assets is likely to grow to about 25.1 B, though Non Currrent Assets Other are likely to grow to (819.6 M).Similar Executives
| Showing other executives | PRESIDENT Age | ||
| John Bryant | Healthcare Realty Trust | 57 | |
| John Spaid | National Health Investors | 64 | |
| Laurie Becker | Healthpeak Properties | 44 | |
| D Mendelsohn | National Health Investors | 59 | |
| Jeff Theiler | Healthpeak Properties | 46 | |
| Mark Theine | Healthpeak Properties | 41 | |
| Timothy Fowler | Universal Health Realty | 69 | |
| J Douglas | Healthcare Realty Trust | 45 | |
| Robert Hull | Healthcare Realty Trust | 52 | |
| Christopher Douglas | Healthcare Realty Trust | 42 | |
| Jeffrey Theiler | Healthpeak Properties | 50 | |
| Daniel Klein | Healthpeak Properties | 56 | |
| Cheryl Ramagano | Universal Health Realty | 61 | |
| Bradley Page | Healthpeak Properties | 60 | |
| Mark Kennedy | Global Medical REIT | N/A | |
| Allen Webb | Global Medical REIT | 50 | |
| Talya NevoHacohen | Sabra Healthcare REIT | 64 | |
| Del Taylor | Healthpeak Properties | 67 | |
| Douglas Whitman | Healthcare Realty Trust | 48 | |
| Charles Boyle | Universal Health Realty | 64 | |
Management Performance
| Return On Equity | -0.003 | ||||
| Return On Asset | 0.0165 |
Ventas Inc Leadership Team
Elected by the shareholders, the Ventas' board of directors comprises two types of representatives: Ventas inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ventas. The board's role is to monitor Ventas' management team and ensure that shareholders' interests are well served. Ventas' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ventas' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edmund III, Chief VP | ||
| T Riney, Executive Vice President Chief Administrative Officer, General Counsel, Secretary, Ethics and Compliance Officer | ||
| Carey JD, General VP | ||
| Jay Gellert, Independent Director | ||
| Richard JD, Senior Advisor | ||
| Maurice Smith, Independent Director | ||
| Douglas Pasquale, Director | ||
| Richard Gilchrist, Independent Director | ||
| Louise Adhikari, VP Communications | ||
| Ryan Shannon, IR Contact Officer | ||
| Robert Probst, Chief Financial Officer, Executive Vice President | ||
| J Hutchens, Executive Vice President - Senior Housing | ||
| Roxanne Martino, Independent Director | ||
| Juan Sanabria, Vice President of Investor Relations | ||
| Justin Hutchens, Executive Officer | ||
| Douglas Crocker, Presiding Independent Director | ||
| Glenn Rufrano, Independent Director | ||
| Randy Sohanaki, Vice President - IT Applications | ||
| Julie Robinson, Senior Investments | ||
| Brian Wood, Chief VP | ||
| John Cobb, Executive Vice President, Chief Investment Officer | ||
| Peter Bulgarelli, Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. | ||
| Richard Riney, Chief Admin. Officer, Executive VP and General Counsel | ||
| Bhavana Devulapally, Senior Vice President, Chief Information Officer | ||
| Michael Embler, Independent Director | ||
| Walter Rakowich, Independent Director | ||
| Debra Cafaro, Chairman of the Board, Chief Executive Officer | ||
| Gregory Liebbe, Senior Vice President Chief Accounting Officer, Controller | ||
| Robert Reed, Independent Director | ||
| Timothy Sanders, Senior Investment Officer | ||
| Christian Cummings, Senior Housing | ||
| Melody Barnes, Independent Director | ||
| James Shelton, Presiding Independent Director | ||
| Todd Lillibridge, Executive VP of Medical Property Operations, CEO of Lillibridge Healthcare Services Inc and President of Lillibridge Healthcare Services Inc | ||
| Matthew Lustig, Independent Director | ||
| Sean Nolan, Independent Director | ||
| Carey Roberts, Executive Vice President General Counsel and Ethics & Compliance Officer | ||
| Marguerite Nader, Independent Director |
Ventas Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ventas a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.003 | ||||
| Return On Asset | 0.0165 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 31.09 B | ||||
| Shares Outstanding | 404.05 M | ||||
| Shares Owned By Insiders | 0.58 % | ||||
| Shares Owned By Institutions | 96.07 % | ||||
| Number Of Shares Shorted | 6.35 M | ||||
| Price To Earning | 909.80 X |
Ventas Investors Sentiment
The influence of Ventas' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ventas. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ventas' public news can be used to forecast risks associated with an investment in Ventas. The trend in average sentiment can be used to explain how an investor holding Ventas can time the market purely based on public headlines and social activities around Ventas Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ventas' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ventas' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ventas' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ventas.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ventas in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ventas' short interest history, or implied volatility extrapolated from Ventas options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ventas Inc is a strong investment it is important to analyze Ventas' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ventas' future performance. For an informed investment choice regarding Ventas Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ventas Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Ventas Stock analysis
When running Ventas' price analysis, check to measure Ventas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventas is operating at the current time. Most of Ventas' value examination focuses on studying past and present price action to predict the probability of Ventas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventas' price. Additionally, you may evaluate how the addition of Ventas to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Ventas' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ventas. If investors know Ventas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ventas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.59) | Dividend Share 1.8 | Earnings Share (0.08) | Revenue Per Share 11.199 | Quarterly Revenue Growth 0.135 |
The market value of Ventas Inc is measured differently than its book value, which is the value of Ventas that is recorded on the company's balance sheet. Investors also form their own opinion of Ventas' value that differs from its market value or its book value, called intrinsic value, which is Ventas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ventas' market value can be influenced by many factors that don't directly affect Ventas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ventas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ventas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ventas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.